40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
7.28%
Cash & equivalents yoy growth below half of CRK's 43.29%. Michael Burry would question if the firm faces a liquidity squeeze. Check for rising debts or negative cash flow.
No Data
No Data available this quarter, please select a different quarter.
7.28%
Below half of CRK's 43.29%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
-2.47%
Receivables growth less than half of CRK's 19.84%. David Dodd might see more conservative credit practices, provided revenue isn't suffering.
6.74%
Higher Inventory Growth compared to CRK's zero value, indicating worse performance.
-16.91%
Other current assets growth < half of CRK's -96.03%. David Dodd sees a leaner approach to short-term items.
-2.40%
Below half of CRK's 12.28%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
11.43%
1.25-1.5x CRK's 10.00%. Bruce Berkowitz notes a significant push to expand capacity faster than competitor.
0.60%
Higher Goodwill Growth compared to CRK's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
0.60%
Higher Goodwill + Intangibles Growth compared to CRK's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.98%
Less than half of CRK's 101.99%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
9.19%
Similar yoy growth to CRK's 10.09%. Walter Schloss finds parallel expansions in non-current assets.
-100.00%
Higher Other Assets Growth compared to CRK's zero value, indicating worse performance.
7.98%
0.75-0.9x CRK's 10.21%. Bill Ackman questions if competitor invests more aggressively for growth.
14.77%
Less than half of CRK's -6.11%. David Dodd sees a more disciplined AP approach or lower volume.
-29.77%
50-75% of CRK's -50.00%. Bruce Berkowitz notes the firm is less reliant on near-term borrowing than competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-80.65%
Higher Other Current Liabilities Growth compared to CRK's zero value, indicating worse performance.
9.30%
Less than half of CRK's -1.56%. David Dodd sees a more disciplined short-term liability approach.
41.40%
Above 1.5x CRK's 27.30%. Michael Burry suspects significant leverage additions. Check coverage.
-100.00%
Both CRK and the company show zero Non-Current Deferred Revenue Growth.
-9.66%
Less than half of CRK's 4.45%. David Dodd sees fewer additions to deferred tax liabilities vs. competitor.
3.44%
Less than half of CRK's -12.96%. David Dodd notes more conservative expansions in non-current obligations.
11.69%
50-75% of CRK's 16.87%. Bruce Berkowitz notes a smaller yoy liability buildup than competitor.
No Data
No Data available this quarter, please select a different quarter.
11.10%
Similar yoy to CRK's 14.74%. Walter Schloss sees parallel expansions in total liabilities.
No Data
No Data available this quarter, please select a different quarter.
7.57%
1.25-1.5x CRK's 6.38%. Bruce Berkowitz notes stronger reinvestment strategy.
-3.56%
50-75% of CRK's -6.94%. Bruce Berkowitz notes relatively lower AOCI expansions.
-100.00%
Higher Other Stockholders' Equity Items Growth compared to CRK's zero value, indicating worse performance.
4.26%
Similar yoy to CRK's 4.48%. Walter Schloss sees parallel net worth trends.
7.98%
0.75-0.9x CRK's 10.21%. Bill Ackman wonders if competitor invests or leverages more aggressively.
No Data
No Data available this quarter, please select a different quarter.
31.58%
1.1-1.25x CRK's 26.64%. Bill Ackman questions if the firm is outpacing competitor in borrowing.
33.43%
1.25-1.5x CRK's 26.15%. Martin Whitman is wary of heavier net leverage vs. competitor.
